{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:36:09Z","timestamp":1784244969534,"version":"3.55.0"},"reference-count":262,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.arr.2026.103097","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:37:42Z","timestamp":1773826662000},"page":"103097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Tau phosphorylation homeostasis: Mechanisms, targets, and therapeutic implications in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"118","author":[{"given":"Shengwen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103097_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107324","article-title":"Discovery of novel quinolin-2-one derivatives as potential GSK-3\u03b2 inhibitors for treatment of Alzheimer\u2019s disease: pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation","volume":"146","author":"Abdo Moustafa","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"Pt 21","key":"10.1016\/j.arr.2026.103097_bib2","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1242\/jcs.113.21.3737","article-title":"C-terminal inhibition of tau assembly in vitro and in Alzheimer\u2019s disease","volume":"113","author":"Abraha","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2026.103097_bib3","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300258120","article-title":"Structure-based design of nanobodies that inhibit seeding of Alzheimer\u2019s patient-extracted tau fibrils","volume":"120","author":"Abskharon","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/ddr449","article-title":"NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy","volume":"21","author":"Ali","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1073\/pnas.94.1.298","article-title":"Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau","volume":"94","author":"Alonso","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40478-018-0562-9","article-title":"Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau","volume":"6","author":"van Ameijde","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib7","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","article-title":"Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice","volume":"30","author":"Andrews-Zwilling","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijbiomac.2020.06.078","article-title":"Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases","volume":"161","author":"Anwar","year":"2020","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103097_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/exnr.2000.7501","article-title":"CSF phosphorylated tau protein and mild cognitive impairment: a prospective study","volume":"166","author":"Arai","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib11","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays","volume":"19","author":"Ashton","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.arr.2026.103097_bib14","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1021\/jm301079z","article-title":"Microtubule stabilizing agents as potential treatment for Alzheimer\u2019s disease and related neurodegenerative tauopathies","volume":"55","author":"Ballatore","year":"2012","journal-title":"J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib15","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","article-title":"Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials","volume":"28","author":"Basheer","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103097_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14482","article-title":"Plasma p-tau217 and neurofilament\/p-tau217 ratio in differentiating Alzheimer\u2019s disease from syndromes associated with frontotemporal lobar degeneration","volume":"21","author":"Benussi","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib17","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1021\/acs.jafc.1c00394","article-title":"Alginate-derived mannuronate oligosaccharide attenuates tauopathy through enhancing autophagy","volume":"69","author":"Bi","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.arr.2026.103097_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcz004","article-title":"Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury","volume":"1","author":"Bittar","year":"2019","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.arr.2026.103097_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S1041610297004973","article-title":"Staging of Alzheimer-related cortical destruction","volume":"9","author":"Braak","year":"1997","journal-title":"Int Psychogeriatr."},{"key":"10.1016\/j.arr.2026.103097_bib20","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/acel.12648","article-title":"Dyrk1 inhibition improves Alzheimer\u2019s disease-like pathology","volume":"16","author":"Branca","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103097_bib21","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/S0021-9258(18)53710-8","article-title":"Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro","volume":"268","author":"Brandt","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.gde.2017.03.014","article-title":"NMNAT: It\u2019s an NAD+ synthase\u2026 It\u2019s a chaperone\u2026 It\u2019s a neuroprotector","volume":"44","author":"Brazill","year":"2017","journal-title":"Curr. Opin. Genet Dev."},{"key":"10.1016\/j.arr.2026.103097_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","article-title":"A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103097_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114066","article-title":"The pivotal role of SUMO-1-JNK-Tau axis in an in vitro model of oxidative stress counteracted by the protective effect of curcumin","volume":"178","author":"Buccarello","year":"2020","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.arr.2026.103097_bib25","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1002\/alz.13784","article-title":"The six brain-specific TAU isoforms and their role in Alzheimer\u2019s disease and related neurodegenerative dementia syndromes","volume":"20","author":"Buchholz","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/1177271920950319","article-title":"Fluid biomarkers for synaptic dysfunction and loss","volume":"15","author":"Camporesi","year":"2020","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.arr.2026.103097_bib27","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.1322360111","article-title":"cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex","volume":"111","author":"Carlyle","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","article-title":"Overview of tau PET molecular imaging","volume":"35","author":"Cassinelli Petersen","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2414176121","article-title":"GSK3\u03b2 phosphorylation catalyzes the aggregation of tau into Alzheimer\u2019s disease-like filaments","volume":"121","author":"Chakraborty","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb8255","article-title":"Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"371","author":"Chang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103097_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12915-023-01798-6","article-title":"The HSP40 family chaperone isoform DNAJB6b prevents neuronal cells from tau aggregation","volume":"21","author":"Chang","year":"2023","journal-title":"BMC Biol."},{"key":"10.1016\/j.arr.2026.103097_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117688","article-title":"Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics","volume":"181","author":"Chen","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.arr.2026.103097_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2018.09.008","article-title":"Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance","volume":"311","author":"Chen","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib34","doi-asserted-by":"crossref","first-page":"20315","DOI":"10.1074\/jbc.M601016200","article-title":"ERK1\/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures","volume":"281","author":"Chong","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/1673-5374.346477","article-title":"Microtubule affinity regulating kinase (MARK\/Par1) isoforms differentially regulate Alzheimer-like TAU missorting and A\u03b2-mediated synapse pathology","volume":"18","author":"Chudobov\u00e1","year":"2023","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2026.103097_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2026.103097_bib37","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1523\/JNEUROSCI.1914-20.2021","article-title":"Frontotemporal lobar dementia mutant tau impairs axonal transport through a protein phosphatase 1\u03b3-dependent mechanism","volume":"41","author":"Combs","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-180792","article-title":"CDK5: a unique CDK and its multiple roles in the nervous system","volume":"68","author":"Cort\u00e9s","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103097_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fneur.2013.00114","article-title":"Are tau aggregates toxic or protective in tauopathies?","volume":"4","author":"Cowan","year":"2013","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00401-010-0716-8","article-title":"Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo","volume":"120","author":"Cowan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1073\/pnas.0809057106","article-title":"Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation","volume":"106","author":"Crouch","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acs.jmedchem.0c00931","article-title":"Glycogen synthase kinase 3\u03b2: a new gold rush in Anti-Alzheimer\u2019s disease multitarget drug discovery?","volume":"64","author":"De Simone","year":"2021","journal-title":"J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0074-7696(08)62588-7","article-title":"Normal and pathological Tau proteins as factors for microtubule assembly","volume":"171","author":"Delacourte","year":"1997","journal-title":"Int Rev. Cytol."},{"key":"10.1016\/j.arr.2026.103097_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114054","article-title":"ARN25068, a versatile starting point towards triple GSK-3\u03b2\/FYN\/DYRK1A inhibitors to tackle tau-related neurological disorders","volume":"229","author":"Demuro","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib45","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.3390\/molecules29184354","article-title":"p38\u03b1 mitogen-activated protein Kinase-An emerging drug target for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Detka","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2026.103097_bib46","article-title":"Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer\u2019s disease","volume":"21","author":"Devanarayan","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib47","article-title":"Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer\u2019s disease","volume":"21","author":"Devanarayan","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1172\/JCI29715","article-title":"The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins","volume":"117","author":"Dickey","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.arr.2026.103097_bib49","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103097_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106446","article-title":"Design, synthesis and bioevaluation of 1,2,4-thiadiazolidine-3,5-dione derivatives as potential GSK-3\u03b2 inhibitors for the treatment of Alzheimer\u2019s disease","volume":"134","author":"Dong","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib51","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.tibs.2004.08.001","article-title":"MARKing tau for tangles and toxicity","volume":"29","author":"Drewes","year":"2004","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.arr.2026.103097_bib52","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","article-title":"Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease","volume":"26","author":"Dujardin","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2026.103097_bib53","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","article-title":"Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert","volume":"99","author":"Engel","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2026.103097_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-023-00646-z","article-title":"TDP-43-regulated cryptic RNAs accumulate in Alzheimer\u2019s disease brains","volume":"18","author":"Estades Ayuso","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103097_bib55","doi-asserted-by":"crossref","first-page":"24977","DOI":"10.1074\/jbc.M000808200","article-title":"Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau\u2019s ability to promote microtubule assembly","volume":"275","author":"Evans","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep19393","article-title":"Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory","volume":"6","author":"F\u00e1","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103097_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108748","article-title":"Dual inhibition of butyrylcholinesterase and p38\u03b1 mitogen-activated protein kinase: a new approach for the treatment of Alzheimer\u2019s disease","volume":"264","author":"Ferjan\u010di\u010d Benetik","year":"2024","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.arr.2026.103097_bib58","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fncel.2019.00574","article-title":"Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington\u2019s Disease","volume":"13","author":"Fern\u00e1ndez-Nogales","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib59","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1021\/bi901090m","article-title":"Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules","volume":"48","author":"Fischer","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2026.103097_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ncb1528","article-title":"Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo","volume":"9","author":"Fulga","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2026.103097_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-020-00404-5","article-title":"Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Gibbons","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103097_bib62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017225118","article-title":"Hydrogen sulfide is neuroprotective in Alzheimer\u2019s disease by sulfhydrating GSK3\u03b2 and inhibiting Tau hyperphosphorylation","volume":"118","author":"Giovinazzo","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib63","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","article-title":"Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization","volume":"9","author":"Goedert","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2026.103097_bib64","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","article-title":"Post-translational modifications of tau protein in Alzheimer\u2019s disease","volume":"112","author":"Gong","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2026.103097_bib65","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib66","doi-asserted-by":"crossref","first-page":"10600","DOI":"10.1074\/jbc.M117.783498","article-title":"Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies","volume":"292","author":"Gu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib67","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/neu.10319","article-title":"Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease","volume":"58","author":"Gunawardena","year":"2004","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103097_bib70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41392-024-01742-2","article-title":"Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2026.103097_bib71","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1021\/acs.jmedchem.1c00382","article-title":"Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo","volume":"64","author":"Halkina","year":"2021","journal-title":"J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.arr.2017.03.002","article-title":"vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings","volume":"36","author":"Hall","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103097_bib73","doi-asserted-by":"crossref","first-page":"23645","DOI":"10.1074\/jbc.M703269200","article-title":"Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis","volume":"282","author":"Hanger","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103097_bib75","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib76","doi-asserted-by":"crossref","first-page":"44525","DOI":"10.1074\/jbc.M207426200","article-title":"Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202\/Thr205 of human tau","volume":"277","author":"Hashiguchi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14336","article-title":"Identification of AS1842856 as a novel small-molecule GSK3\u03b1\/\u03b2 inhibitor against Tauopathy by accelerating GSK3\u03b1\/\u03b2 exocytosis","volume":"24","author":"He","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103097_bib78","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1083\/jcb.107.4.1449","article-title":"Tau proteins: the molecular structure and mode of binding on microtubules","volume":"107","author":"Hirokawa","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.arr.2026.103097_bib79","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00401-002-0581-1","article-title":"Inverse association of Pin1 and tau accumulation in Alzheimer\u2019s disease hippocampus","volume":"104","author":"Holzer","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib80","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00401-020-02261-4","article-title":"The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"141","author":"Hondius","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib81","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41591-025-03617-7","article-title":"Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer\u2019s disease","volume":"31","author":"Horie","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103097_bib82","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1038\/s41467-021-25635-y","article-title":"DnaJC7 binds natively folded structural elements in tau to inhibit amyloid formation","volume":"12","author":"Hou","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12931","article-title":"Methyl donor supplementation reduces phospho-Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy","volume":"49","author":"van Hummel","year":"2023","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib84","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69601","article-title":"Hsp40s play complementary roles in the prevention of tau amyloid formation","volume":"10","author":"Irwin","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.arr.2026.103097_bib85","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41591-024-03400-0","article-title":"Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer\u2019s disease","volume":"31","author":"Islam","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103097_bib86","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-\u03b2 toxicity in Alzheimer\u2019s mice","volume":"354","author":"Ittner","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103097_bib87","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/brain\/awz268","article-title":"The bivariate distribution of amyloid-\u03b2 and tau: relationship with established neurocognitive clinical syndromes","volume":"142","author":"Jack","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103097_bib88","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106441","article-title":"Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets","volume":"193","author":"Jadhav","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103097_bib90","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103097_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70208","article-title":"A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer\u2019s disease","volume":"21","author":"Janelidze","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib92","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3530417","article-title":"Protein phosphatase 2A: a highly regulated family of serine\/threonine phosphatases implicated in cell growth and signalling","volume":"353","author":"Janssens","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.arr.2026.103097_bib93","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors as potential therapeutics","volume":"61","author":"Jarhad","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib94","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/nu13113744","article-title":"Therapeutic potential of mitophagy-inducing microflora metabolite, urolithin A for Alzheimer\u2019s disease","volume":"13","author":"Jayatunga","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2026.103097_bib95","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.bpj.2010.06.056","article-title":"Monte carlo simulations of tau proteins: effect of phosphorylation","volume":"99","author":"Jho","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2026.103097_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101208","article-title":"Synaptic basis of Alzheimer\u2019s disease: Focus on synaptic amyloid beta, P-tau and mitochondria","volume":"65","author":"John","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103097_bib97","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cm.970240405","article-title":"Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or TAU","volume":"24","author":"Jung","year":"1993","journal-title":"Cell Motil. Cytoskelet."},{"key":"10.1016\/j.arr.2026.103097_bib98","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s42003-024-06879-y","article-title":"Enhanced homeostatic sleep response and decreased neurodegenerative proteins in cereblon knock-out mice","volume":"7","author":"Jung","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2026.103097_bib99","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41467-024-46876-7","article-title":"Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer\u2019s disease neuropathology","volume":"15","author":"Kac","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0896-6273(00)00124-0","article-title":"Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I","volume":"28","author":"Kamal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2026.103097_bib101","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1523\/JNEUROSCI.0560-11.2011","article-title":"Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases","volume":"31","author":"Kanaan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib102","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1523\/JNEUROSCI.0387-15.2015","article-title":"C-terminally truncated forms of tau, but not full-length Tau or Its C-terminal fragments, are released from neurons independently of cell death","volume":"35","author":"Kanmert","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib103","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-006-0049-9","article-title":"Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions","volume":"111","author":"Kannanayakal","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mcn.2010.08.015","article-title":"Which way to go? Cytoskeletal organization and polarized transport in neurons","volume":"46","author":"Kapitein","year":"2011","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib105","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cell.2020.04.025","article-title":"Visualizing and modulating mitophagy for therapeutic studies of neurodegeneration","volume":"181","author":"Katayama","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103097_bib106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10571-022-01191-x","article-title":"The role of ERK1\/2 pathway in the pathophysiology of Alzheimer\u2019s disease: an overview and update on new developments","volume":"43","author":"Khezri","year":"2023","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib107","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1074\/jbc.M115.636852","article-title":"Insulin resistance prevents AMPK-induced Tau dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation","volume":"290","author":"Kim","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib108","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1074\/jbc.M112.433326","article-title":"Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites","volume":"288","author":"Kimura","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib109","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroscience.2013.04.042","article-title":"Decisive role of Reelin signaling during early stages of Alzheimer\u2019s disease","volume":"246","author":"Krstic","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2026.103097_bib110","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00406-025-02013-z","article-title":"Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer\u2019s disease and corticobasal syndrome","volume":"275","author":"Kurz","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib111","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103097_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40478-016-0317-4","article-title":"Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer\u2019s disease","volume":"4","author":"Lau","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106725","article-title":"Inhibition of CDK4\/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A\/STAT3 signaling","volume":"190","author":"Lee","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2026.103097_bib114","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.015574","article-title":"Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation","volume":"296","author":"Lee","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103097_bib116","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00259-018-4242-6","article-title":"Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer\u2019s disease","volume":"46","author":"Leuzy","year":"2019","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103097_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114805","article-title":"STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells","volume":"377","author":"Li","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib118","doi-asserted-by":"crossref","first-page":"15938","DOI":"10.1074\/jbc.M314116200","article-title":"Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib119","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115817","article-title":"Targeting protein kinases for the treatment of Alzheimer\u2019s disease: Recent progress and future perspectives","volume":"261","author":"Li","year":"2023","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112580","article-title":"Identification and analysis of a selective DYRK1A inhibitor","volume":"146","author":"Lin","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.arr.2026.103097_bib122","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib123","doi-asserted-by":"crossref","first-page":"50078","DOI":"10.1074\/jbc.M406109200","article-title":"Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain","volume":"279","author":"Liu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106168","article-title":"Discovery of novel \u03b2-carboline-1,2,3-triazole hybrids as AChE\/GSK-3\u03b2 dual inhibitors for Alzheimer\u2019s disease treatment","volume":"129","author":"Liu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113554","article-title":"Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3\u03b2\/DYRK1A dual inhibitors for the treatment of Alzheimer\u2019s disease","volume":"222","author":"Liu","year":"2021","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114095","article-title":"Discovery of novel \u03b2-carboline derivatives as selective AChE inhibitors with GSK-3\u03b2 inhibitory property for the treatment of Alzheimer\u2019s disease","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib127","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.3390\/ijms25158428","article-title":"\u03b1-tocotrienol protects neurons by preventing Tau hyperphosphorylation via inhibiting microtubule affinity-regulating kinase activation","volume":"25","author":"Liu","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103097_bib128","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13159","article-title":"TDP-43 and tau concurrence in the entorhinal subfields in primary age-related tauopathy and preclinical Alzheimer\u2019s disease","volume":"33","author":"Llamas-Rodr\u00edguez","year":"2023","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2026.103097_bib129","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.0701055104","article-title":"Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies","volume":"104","author":"Luo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115415","article-title":"Oxazole-4-carboxamide\/butylated hydroxytoluene hybrids with GSK-3\u03b2 inhibitory and neuroprotective activities against Alzheimer\u2019s disease","volume":"256","author":"Luo","year":"2023","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib131","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51859","article-title":"Nicotinamide mononucleotide adenylyltransferase uses its NAD+ substrate-binding site to chaperone phosphorylated Tau","volume":"9","author":"Ma","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.arr.2026.103097_bib132","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","article-title":"The use of Tau PET to stage alzheimer disease according to the braak staging framework","volume":"64","author":"Macedo","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103097_bib133","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/hmg\/dds072","article-title":"Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons: implications for mitochondrial dysfunction and neuronal damage","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib134","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JAD-130275","article-title":"Abnormal interaction of oligomeric amyloid-\u03b2 with phosphorylated tau: implications to synaptic dysfunction and neuronal damage","volume":"36","author":"Manczak","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103097_bib135","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib136","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bbadis.2012.02.017","article-title":"Dynamin-related protein 1 heterozygote knockout mice do not have synaptic and mitochondrial deficiencies","volume":"1822","author":"Manczak","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.arr.2026.103097_bib137","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1083\/jcb.200401085","article-title":"MARK\/PAR1 kinase is a regulator of microtubule-dependent transport in axons","volume":"167","author":"Mandelkow","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.arr.2026.103097_bib138","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1523\/JNEUROSCI.16-18-05727.1996","article-title":"A spatial gradient of tau protein phosphorylation in nascent axons","volume":"16","author":"Mandell","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib139","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","article-title":"Tau protein phosphatases in Alzheimer\u2019s disease: the leading role of PP2A","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103097_bib140","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2009.03.008","article-title":"The tau of MARK: a polarized view of the cytoskeleton","volume":"34","author":"Matenia","year":"2009","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.arr.2026.103097_bib141","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","article-title":"Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau","volume":"97","author":"McInnes","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2026.103097_bib142","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.emboj.7600650","article-title":"Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1\/2 activation","volume":"24","author":"Medina","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2026.103097_bib143","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13000","article-title":"Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer\u2019s disease","volume":"18","author":"Melchior","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103097_bib144","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 Pathology in Alzheimer\u2019s Disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103097_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570045","article-title":"Tau Protein and Its Role in Blood-Brain Barrier Dysfunction","volume":"13","author":"Michalicova","year":"2020","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0301-0082(99)00042-8","article-title":"JNK and p38 stresskinases--degenerative effectors of signal-transduction-cascades in the nervous system","volume":"61","author":"Mielke","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib147","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103097_bib148","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1038\/s41467-022-31396-z","article-title":"Hsp multichaperone complex buffers pathologically modified Tau","volume":"13","author":"Moll","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib149","doi-asserted-by":"crossref","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","article-title":"Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation","volume":"287","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib150","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/940603","article-title":"Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer\u2019s disease","volume":"2013","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2013","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.arr.2026.103097_bib151","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2016.03.044","article-title":"Tau pathology-mediated presynaptic dysfunction","volume":"325","author":"Moreno","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2026.103097_bib152","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","article-title":"Defective mitophagy and synaptic degeneration in Alzheimer\u2019s disease: Focus on aging, mitochondria and synapse","volume":"172","author":"Morton","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2026.103097_bib153","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103097_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000034","article-title":"Structural polymorphism of 441-residue tau at single residue resolution","volume":"7","author":"Mukrasch","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.arr.2026.103097_bib155","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/acn3.308","article-title":"Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathy","volume":"3","author":"Musiek","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib156","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41419-024-06927-9","article-title":"Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects","volume":"15","author":"Nair","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2026.103097_bib157","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/BST20120091","article-title":"Tau alternative splicing in familial and sporadic tauopathies","volume":"40","author":"Niblock","year":"2012","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.arr.2026.103097_bib158","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41380-023-02321-7","article-title":"Cortical microstructural associations with CSF amyloid and pTau","volume":"29","author":"Nir","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103097_bib159","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103097_bib160","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.celrep.2018.12.085","article-title":"Microtubules deform the nuclear membrane and disrupt nucleocytoplasmic transport in Tau-mediated frontotemporal dementia","volume":"26","author":"Paonessa","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2026.103097_bib161","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/hmg\/dds100","article-title":"Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2","volume":"21","author":"Park","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib162","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41467-023-36519-8","article-title":"Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1150940","article-title":"Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3\u03b1\/\u03b2","volume":"14","author":"Park","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2026.103097_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.136860","article-title":"Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor","volume":"282","author":"Peng","year":"2024","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103097_bib165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tins.2010.03.006","article-title":"Retrograde axonal transport: pathways to cell death?","volume":"33","author":"Perlson","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib166","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0912718107","article-title":"No difference in kinetics of tau or histone phosphorylation by CDK5\/p25 versus CDK5\/p35 in vitro","volume":"107","author":"Peterson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib167","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41467-024-45851-6","article-title":"Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction","volume":"15","author":"Pinzi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib168","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer\u2019s disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies","volume":"24","author":"Pires","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103097_bib169","doi-asserted-by":"crossref","first-page":"34298","DOI":"10.1074\/jbc.M102780200","article-title":"Inhibition of protein phosphatase 2A overrides tau protein kinase I\/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse","volume":"276","author":"Planel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/cells8030260","article-title":"Structure based design and molecular docking studies for phosphorylated Tau inhibitors in Alzheimer\u2019s disease","volume":"8","author":"Pradeepkiran","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103097_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101191","article-title":"Defective mitophagy in Alzheimer\u2019s disease","volume":"64","author":"Pradeepkiran","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103097_bib172","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/hmg\/ddab244","article-title":"Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease","volume":"31","author":"Pradeepkiran","year":"2021","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112918","article-title":"Are mitophagy enhancers therapeutic targets for Alzheimer\u2019s disease?","volume":"149","author":"Pradeepkiran","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.arr.2026.103097_bib174","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/10738584221139761","article-title":"Mitochondria in Aging and Alzheimer\u2019s Disease: Focus on Mitophagy","volume":"30","author":"Pradeepkiran","year":"2024","journal-title":"Neuroscientist"},{"key":"10.1016\/j.arr.2026.103097_bib175","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1523\/JNEUROSCI.0525-08.2008","article-title":"Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress","volume":"28","author":"Press","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib176","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/bi5014613","article-title":"Nuclear magnetic resonance spectroscopy characterization of interaction of Tau with DNA and its regulation by phosphorylation","volume":"54","author":"Qi","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2026.103097_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1343962","article-title":"The role of the Pin1-cis P-tau axis in the development and treatment of vascular contribution to cognitive impairment and dementia and preeclampsia","volume":"12","author":"Qiu","year":"2024","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.arr.2026.103097_bib178","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jare.2021.03.012","article-title":"Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer\u2019s disease via inhibiting neuropathology and modulating gut microbiota","volume":"35","author":"Qu","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.arr.2026.103097_bib179","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11064-005-2483-9","article-title":"Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1","volume":"30","author":"Rahman","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2026.103097_bib180","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103097_bib181","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.brainresrev.2005.03.004","article-title":"Are mitochondria critical in the pathogenesis of Alzheimer\u2019s disease? Brain Res","volume":"49","author":"Reddy","year":"2005","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.arr.2026.103097_bib182","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/cells8050488","article-title":"Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103097_bib183","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/jim-2016-000240","article-title":"Protective effects of a natural product, curcumin, against amyloid \u03b2 induced mitochondrial and synaptic toxicities in Alzheimer\u2019s disease","volume":"64","author":"Reddy","year":"2016","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.arr.2026.103097_bib184","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/ddx052","article-title":"Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Reddy","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-170051","article-title":"Mitochondria-Division Inhibitor 1 Protects Against Amyloid-\u03b2 induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer\u2019s Disease","volume":"58","author":"Reddy","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103097_bib186","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1073858416633439","article-title":"Physiological and Pathophysiological Implications of Synaptic Tau","volume":"23","author":"Regan","year":"2017","journal-title":"Neuroscientist"},{"key":"10.1016\/j.arr.2026.103097_bib187","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s42003-024-06572-0","article-title":"Selenoprotein W modulates tau homeostasis in an Alzheimer\u2019s disease mouse model","volume":"7","author":"Ren","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2026.103097_bib188","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4103\/1673-5374.360165","article-title":"Cdk5 and aberrant cell cycle activation at the core of neurodegeneration","volume":"18","author":"Requejo-Aguilar","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2026.103097_bib189","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19809","article-title":"TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau","volume":"5","author":"Rousseaux","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.arr.2026.103097_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101905","article-title":"Folding or holding?-Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease","volume":"298","author":"Rutledge","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib191","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neurobiolaging.2005.10.019","article-title":"The aging brain: accumulation of DNA damage or neuron loss?","volume":"28","author":"Rutten","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103097_bib192","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of Tau. A functional link between down syndrome and Alzheimer disease","volume":"282","author":"Ryoo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib193","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/s41380-024-02502-y","article-title":"The Alzheimer\u2019s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons","volume":"29","author":"Saha","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103097_bib194","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1111\/j.1460-9568.2007.05555.x","article-title":"Assembly of two distinct dimers and higher-order oligomers from full-length tau","volume":"25","author":"Sahara","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib195","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/hmg\/ddz120","article-title":"Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262","volume":"28","author":"Saito","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2026.103097_bib196","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pneurobio.2010.10.006","article-title":"Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer\u2019s disease","volume":"93","author":"Salminen","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib197","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103097_bib198","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108870119","article-title":"Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation","volume":"119","author":"Saroja","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib199","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-019-02017-9","article-title":"BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation","volume":"138","author":"Sartori","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib200","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1096\/fj.201902731RR","article-title":"Neuronal deficiency of p38\u03b1-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer\u2019s mouse models","volume":"34","author":"Schn\u00f6der","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2026.103097_bib201","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1073\/pnas.1916895117","article-title":"Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3\u03b2 in Alzheimer\u2019s disease","volume":"117","author":"Sen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","article-title":"Tau protein as a differential biomarker of tauopathies","volume":"1739","author":"Sergeant","year":"2005","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.arr.2026.103097_bib203","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/alz.13533","article-title":"Novel avenues of tau research","volume":"20","author":"Sexton","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib204","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1074\/jbc.M110.204453","article-title":"Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease","volume":"286","author":"Shi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib205","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.3390\/ijms221810145","article-title":"Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction","volume":"22","author":"Siano","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103097_bib206","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1021\/bi061920i","article-title":"NMR investigation of the interaction between the neuronal protein tau and the microtubules","volume":"46","author":"Sillen","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2026.103097_bib207","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/bpa.12505","article-title":"Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi","volume":"28","author":"Smith","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2026.103097_bib208","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/acscentsci.2c01369","article-title":"Chemical knockdown of phosphorylated p38 mitogen-activated protein kinase (MAPK) as a novel approach for the treatment of Alzheimer\u2019s disease","volume":"9","author":"Son","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.arr.2026.103097_bib209","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0896-6273(00)80250-0","article-title":"Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A","volume":"17","author":"Sontag","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2026.103097_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107811","article-title":"Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3\u03b2\/A\u03b2 aggregation inhibitor and anti-Alzheimer\u2019s agent","volume":"153","author":"Sukanya","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib211","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection","volume":"286","author":"Sultan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib212","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1039\/C9FO00709A","article-title":"Diet control to achieve euglycaemia induces tau hyperphosphorylation via AMPK activation in the hippocampus of diabetic rats","volume":"11","author":"Sung","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.arr.2026.103097_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101977","article-title":"Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase","volume":"298","author":"Tabassum","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib214","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","article-title":"Bridging integrator 1 (BIN1): form, function, and Alzheimer\u2019s disease","volume":"19","author":"Tan","year":"2013","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.arr.2026.103097_bib215","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1093\/brain\/awv220","article-title":"TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes","volume":"138","author":"Tan","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103097_bib216","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/cells8030267","article-title":"Why is NMNAT Protective against Neuronal Cell Death and Axon Degeneration, but Inhibitory of Axon Regeneration?","volume":"8","author":"Tang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103097_bib217","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer\u2019s disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib218","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00401-024-02744-8","article-title":"The influence of APOE\u03b54 on the pTau interactome in sporadic Alzheimer\u2019s disease","volume":"147","author":"Thierry","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib219","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-021-02295-2","article-title":"TDP-43 interacts with pathological \u03c4 protein in Alzheimer\u2019s disease","volume":"141","author":"Tom\u00e9","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib220","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2418470","article-title":"Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-\u03b2 formation","volume":"39","author":"Tu","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib221","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/nan.12163","article-title":"Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer\u2019s disease","volume":"40","author":"Ueberham","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib222","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36374-4","article-title":"Phosphorylation of nuclear Tau is modulated by distinct cellular pathways","volume":"8","author":"Ulrich","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103097_bib223","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1073\/pnas.0607919104","article-title":"Multiple-motor based transport and its regulation by Tau","volume":"104","author":"Vershinin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103097_bib224","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00401-010-0759-x","article-title":"AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer\u2019s disease and other tauopathies","volume":"121","author":"Vingtdeux","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103097_bib225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2014.00084","article-title":"A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions","volume":"8","author":"Violet","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib226","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nbd.2015.09.003","article-title":"Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo","volume":"82","author":"Violet","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103097_bib227","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57354","article-title":"Alzheimer\u2019s disease risk gene BIN1 induces Tau-dependent network hyperexcitability","volume":"9","author":"Voskobiynyk","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.arr.2026.103097_bib228","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s12035-020-01955-w","article-title":"Upregulation of AMPK Ameliorates Alzheimer\u2019s Disease-Like Tau Pathology and Memory Impairment","volume":"57","author":"Wang","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib229","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.arr.2026.103097_bib230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2026.103097_bib231","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/brain\/awae346","article-title":"A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests","volume":"148","author":"Warmenhoven","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103097_bib232","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1021\/acs.jmedchem.3c01696","article-title":"Psychoplastogenic DYRK1A inhibitors with therapeutic effects relevant to Alzheimer\u2019s disease","volume":"67","author":"Warren","year":"2024","journal-title":"J. Med Chem."},{"key":"10.1016\/j.arr.2026.103097_bib233","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","article-title":"The role of DYRK1A in neurodegenerative diseases","volume":"278","author":"Wegiel","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.arr.2026.103097_bib234","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax6999","article-title":"The mechanism of Hsp90-induced oligomerizaton of Tau","volume":"6","author":"Weickert","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2026.103097_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106356","article-title":"Trajectories of CSF and plasma biomarkers across Alzheimer\u2019s disease continuum: disease staging by NF-L, p-tau181, and GFAP","volume":"189","author":"Wojda\u0142a","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103097_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105413","article-title":"Identification of late-stage tau accumulation using plasma phospho-tau217","volume":"109","author":"Woo","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2026.103097_bib237","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1096\/fj.201902230RR","article-title":"A\u03b2 monomer induces phosphorylation of Tau at Ser-214 through \u03b22AR-PKA-JNK signaling pathway","volume":"34","author":"Wu","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2026.103097_bib238","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103097_bib239","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/cdd.2011.2","article-title":"DAPK activates MARK1\/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity","volume":"18","author":"Wu","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2026.103097_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.129074","article-title":"Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule","volume":"259","author":"Wu","year":"2024","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103097_bib241","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ncb0505-435","article-title":"Phosphorylation-specific prolyl isomerization: is there an underlying theme?","volume":"7","author":"Wulf","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2026.103097_bib242","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s12035-020-02174-z","article-title":"Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377","volume":"58","author":"Xu","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib243","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40035-024-00454-5","article-title":"CD2AP deficiency aggravates Alzheimer\u2019s disease phenotypes and pathology through p38 MAPK activation","volume":"13","author":"Xue","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103097_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117236","article-title":"Synthesis and biological evaluation of novel pyrrolo[2,3-b]pyridine derivatives as potent GSK-3\u03b2 inhibitors for treating Alzheimer\u2019s disease","volume":"285","author":"Xun","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.arr.2026.103097_bib245","doi-asserted-by":"crossref","DOI":"10.1038\/s41538-021-00084-5","article-title":"Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway","volume":"5","author":"Yamamoto","year":"2021","journal-title":"NPJ Sci. Food"},{"key":"10.1016\/j.arr.2026.103097_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153624","article-title":"Bushen-Huatan-Yizhi formula reduces spatial learning and memory challenges through inhibition of the GSK-3\u03b2\/CREB pathway in AD-like model rats","volume":"90","author":"Yang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.arr.2026.103097_bib247","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1021\/acs.jmedchem.1c00160","article-title":"Discovery of novel tacrine-pyrimidone hybrids as potent dual AChE\/GSK-3 inhibitors for the treatment of Alzheimer\u2019s disease","volume":"64","author":"Yao","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2026.103097_bib248","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/hmg\/ddr576","article-title":"A critical role for the PAR-1\/MARK-tau axis in mediating the toxic effects of A\u03b2 on synapses and dendritic spines","volume":"21","author":"Yu","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2026.103097_bib249","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/emboj.2013.207","article-title":"Amyloid-\u03b2 oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin","volume":"32","author":"Zempel","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2026.103097_bib250","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/nan.12378","article-title":"Review: Tau in biofluids - relation to pathology, imaging and clinical features","volume":"43","author":"Zetterberg","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2026.103097_bib251","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature06721","article-title":"NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration","volume":"452","author":"Zhai","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103097_bib252","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6931","article-title":"\u03b2-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2\/tau cascade","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103097_bib253","article-title":"Activation of transient receptor potential vanilloid 1 ameliorates tau accumulation-induced synaptic damage and cognitive dysfunction via autophagy enhancement","volume":"30","author":"Zhang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2026.103097_bib254","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-018-0300-0","article-title":"Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy","volume":"35","author":"Zhang","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.arr.2026.103097_bib255","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/brain\/awab134","article-title":"Amyloid-\u03b2 toxicity modulates tau phosphorylation through the PAX6 signalling pathway","volume":"144","author":"Zhang","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103097_bib256","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1021\/acs.jafc.7b01465","article-title":"Long-Term Dietary Supplementation with Selenium-Enriched Yeast Improves Cognitive Impairment, Reverses Synaptic Deficits, and Mitigates Tau Pathology in a Triple Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"65","author":"Zhang","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.arr.2026.103097_bib257","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/alz.12370","article-title":"Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases","volume":"18","author":"Zhao","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103097_bib258","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41392-021-00669-2","article-title":"A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies","volume":"6","author":"Zheng","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2026.103097_bib259","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15295","article-title":"Tau association with synaptic vesicles causes presynaptic dysfunction","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103097_bib260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103970","article-title":"Human tau accumulation promotes glycogen synthase kinase-3\u03b2 acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration","volume":"78","author":"Zhou","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2026.103097_bib261","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41401-020-00562-8","article-title":"Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer\u2019s disease rat model","volume":"42","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.arr.2026.103097_bib262","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2009.01.013","article-title":"Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy","volume":"209","author":"Zilka","year":"2009","journal-title":"J. Neuroimmunol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:03:32Z","timestamp":1778821412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":262,"alternative-id":["S1568163726000899"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103097","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tau phosphorylation homeostasis: Mechanisms, targets, and therapeutic implications in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103097"}}